> France's DrugAbuse Science plans to raise $25.2 million in an IPO. Much of that money will be used to mount late-stage trials of Naltrexone Depot. The market for drug and alcohol abuse therapies has been growing steadily. Report
> Powerful U.S. Senator Chuck Grassley (R-IA) says he plans to confront the Department of Health and Human Services over information about the controversial antibiotic Ketek that he says was never disclosed by the FDA. Report (WSJ sub. req.)
> Akzo Nobel's Nobilon International business, active in the field of human vaccines, is to work together with the Dutch Erasmus Medical Center's spin-off CoroNovative BV to expand and accelerate CoroNovative's virus discovery program. Release
> Shares of Covance were on the rise after it announced a $187 million contract. Report
> First Horizon Pharmaceutical has gained orphan status for an experimental therapy that prevents drooling in children with neurological conditions. Report
> Advanced Magnetics stock surged on the news that an independent committee found no safety concerns involved in a late-stage study of a new product--ferumoxytol iron replacement therapy. Report
And Finally... An advocacy group has sued Kentucky Fried Chicken in an effort to force the company to stop using partially hydrogenated oils in the Colonel's secret recipe. Article